Codes ATC:
R03AC02
EMLc
Indication
Asthma
Code ICD11:
CA23
INN
Salbutamol
Type de médicament
Chemical agent
Type de liste
Liste de base
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
500 µg per mL in 1 mL ampoule (as sulfate) ;
500 µg per mL in 5 mL ampoule (as sulfate)
Respiratory > Inhalation > solution: 100 µg per actuation in pressurized metered dose inhaler (as sulfate) ; 2.5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers ; 5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers ; 5 mg per mL in multi-dose bottle (as sulfate) for use in nebulizers
Respiratory > Inhalation > solution: 100 µg per actuation in pressurized metered dose inhaler (as sulfate) ; 2.5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers ; 5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers ; 5 mg per mL in multi-dose bottle (as sulfate) for use in nebulizers
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Wikipédia
DrugBank
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations of essential medicines for children, the Expert Committee recommended the following changes to the listing of salbutamol on the EML and EMLc:
- update the listing description of inhalation delivery systems for consistency across the Model Lists and to better reflect product characteristics.
- amend the listed strength of salbutamol injection from 50 micrograms/mL in 5 mL ampoule to 500 micrograms/mL in 1 mL and 5 mL ampoules.